Exhaled Breath Condensate : An Update - 18/10/18
Doi : 10.1016/j.iac.2018.06.002
Michael D. Davis, RRT, PhD a, ⁎ 
, Alison J. Montpetit, RN, PhD b
, Alison J. Montpetit, RN, PhD b a Division of Pulmonary Medicine, Children’s Hospital of Richmond at VCU, Hermes A. Kontos Medical Sciences Building, Room 215, 1217 East Marshall Street, Richmond, VA 23298, USA
b VCU Medical Center, Department of Emergency Medicine, Box 980401, Richmond, VA 23298-0401, USA
∗Corresponding author.
Résumé |
Exhaled breath condensate (EBC) is a promising source of biomarkers of lung disease. EBC research and utility has increased substantially over the past 2 decades. This review summarizes many of the factors regarding the composition of EBC, its collection, and analysis for the utility of both clinicians and researchers.
Le texte complet de cet article est disponible en PDF.Keywords : EBC, Exhaled breath condensate, Exhaled breath, Exhaled biomarkers
Plan
| This article is an update of the previously published article on “Exhaled Breath Condensate: An Overview” in the August 2012 issue of the Immunology and Allergy Clinics of North America. |
|
| Disclosure Statement: M.D. Davis is currently supported by an investigator-initiated award from Mallinckrodt Pharmaceuticals. |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 38 - N° 4
P. 667-678 - novembre 2018 Retour au numéro
Article précédent
- Molecular Endotypes Contribute to the Heterogeneity of Asthma
- Erwin W. Gelfand, Michaela Schedel
- Biomarkers in Chronic Rhinosinusitis with Nasal Polyps
- Alan D. Workman, Michael A. Kohanski, Noam A. Cohen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?